NovoCure
NVCR
NVCR
264 hedge funds and large institutions have $4.1B invested in NovoCure in 2020 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 95 increasing their positions, 80 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
14% less capital invested
Capital invested by funds: $4.75B → $4.1B (-$647M)
28% less call options, than puts
Call options by funds: $49.9M | Put options by funds: $69.7M
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
264
Holding in Top 10
4
Calls
$49.9M
Puts
$69.7M
Top Buyers
| 1 | +$55.3M | |
| 2 | +$54.2M | |
| 3 | +$47.9M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$36M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$21.8M |
Top Sellers
| 1 | -$83.1M | |
| 2 | -$81.3M | |
| 3 | -$44.7M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$39.3M |
| 5 |
State Street
Boston,
Massachusetts
|
-$38.9M |